Shorter Radiation Course Stops Cancer Growth in High-risk Prostate Cancer Patients
Hypofractionated radiation treatment, a newer type of radiation treatment that delivers higher doses of radiation in fewer treatments than conventional radiation therapy, is significantly more effective than the older method in stopping cancer growth in high risk patients and causes no increase in negative side effects, an Italian clinical trial shows.
Short Course High-Dose Radiation (IMRT) Looks Safe and Effective for Higher-Risk Prostate Cancer
ASTRO – A shorter, 5-week course of radiation treatment that delivers higher doses of radiation in fewer sessions, known as hypofractionation, appears just as effective and as safe for moderate and higher risk prostate cancer as standard radiation therapy, yet is delivered in two-and-a-half weeks less time.
Magnetic resonance-guided focused ultrasound surgery (MRgFUS), a noninvasive thermal ablation technique that has been shown to be clinically effective in the treatment of uterine fibroids, is now being evaluated as a method for treating painful bone metastases.
Now physicians in North America are running a full scale clinical trial to see if the method really does work as well or better than traditional pain management methods.